Hormona secosteroide

17 REFERENZEN 1. Pilz S, Vitamin D status and arterial hypertension: a systematic review. Nat. Rev. Cardiol. 2009; 6: Reichel H, Koeffler HP, Norman AW, The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 1989; 320: Holick MF, Vitamin D: Photobiology, Metabolism, etc. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, American Society for Bone and Mineral Research. 3 rd Ed. Lippincott-Raven, Philadelphia, 1996; Souberbielle JC, Evaluating vitamin D status. Implications for preventing and managing osteoporosis and other chronic diseases. Joint Bone Spine 2006; 73: Cavalier E, Vitamin D: current status and perspectives. Clin. Chem. Lab Med 2009; 47(2): Peterlik M, Vitamin D and calcium insufficiency-related chronic diseases: an emerging world-wide public health problem. Int. J. Environ. Res. Public Health 2009; 6: Grant WB, Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Prog. Biophys. Mol. Biol. 2009; 99: Holick MF, Vitamin D deficiency. N. Engl. J. Med. 2007; 357: Autier P, Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med. 2007; 167(16): Bischoff-Ferrari HA, Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: Steingrimsdottir L, Relationship between serum parathyroid hormone Levels, vitamin D sufficiency, and calcium intake. JAMA 2005; 294(18): Grant WB, Current impediments to acceptance of the ultraviolet-bvitamin D-cancer hypothesis. Anticancer Res. 2009; 29: Pilz S, Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008; 9: Bischoff-Ferrari HA, Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009; 339:b Wielders JP, Wijnberg FA. Preanalytical stability of 25(OH)-Vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin Chem 2009;55: Qualigen, Inc. Carlsbad, CA USA Technischer Support: +1 (760) (877) MDSS GmbH Schiffgraben Hannover, Deutschland 2013 Qualigen, Inc. Alle Rechte vorbehalten. Qualigen und FastPack sind eingetragene Warenzeichen von Qualigen, Inc. Alle anderen Markenzeichen sind Eigentum der jeweiligen Besitzer. FastPack IP und FastPack Vitamin D Immunoassay DEU-9 P/N Rev. 003 (08/13)

The sequestration of 25-OHD in adipose tissue has been traditionally accepted as true. In such setting, adipose tissue functions as storage for 25-OHD with a half-life of approximately two months. However, it is unclear in the literature whether vitamin D clearing in cases of toxicity varies with age. Hypercalcemia may continue for more than six months after the onset of toxicity. Thus, patients should be followed up until 25-hydroxyvitamin D and calcium levels return to normal, due to the risk of recurrence. 6 , 16

Hormona secosteroide

hormona secosteroide

Media:

hormona secosteroide

http://buy-steroids.org